G2 Bio Companies

G2 Bio Companies was founded in 2021 and is headquartered in Philadelphia, Pennsylvania. It was co-founded by Dr. James Wilson and Dr. Tachi Yamada from the University of Pennsylvania’s gene therapy program, along with Temasek. The company aims to develop potential next-generation gene therapy candidates originating from the University of Pennsylvania's gene therapy initiative.